Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Antiherpes agent will enter phase II, Abbott says

May 19, 1998

Eisai selects new triazole antifungal for further development

May 15, 1998

Scriptgen and Boston University synthesize new antibiotics

May 15, 1998

Antifungal agents disclosed by Nippon Soda

May 15, 1998

Microbial product acts as ergosterol biosynthesis inhibitor in in vitro screen

May 14, 1998

Neuraminic acid derivatives claimed by Sankyo for influenza

May 14, 1998

Roche presents series with potent activity against HSV thymidine kinase

May 14, 1998

IntraBiotics obtains certain rights to ramoplanin

May 14, 1998

Development status of HMR-3647

May 14, 1998

Novel water-soluble azoles for both oral and parenteral treatment of fungal infections

May 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...